Choroidal neovascularization

Frances E. Kane, Peter A Campochiaro

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Despite substantial recent progress in treatment development, choroidal neovascularization (CNV) remains one of the most challenging problems faced by retina specialists. It is a common cause of severe visual loss in patients with age-related macular degeneration (AMD) and younger patients with one of many diseases that affect the choroid-Bruch’s membrane-retinal pigment epithelium (RPE) complex, including but not limited to ocular histoplasmosis, myopic degeneration, angioid streaks, and multifocal choroiditis. As our understanding of the molecular pathogenesis of CNV is increasing, new treatments are being developed which specifically target molecules that are involved. Therefore, it is critical to continue to elucidate the molecular mechanisms involved in CNV.

Original languageEnglish (US)
Title of host publicationAge-Related Macular Degeneration, Second Edition
PublisherCRC Press
Pages87-96
Number of pages10
ISBN (Electronic)9781420019865
ISBN (Print)9780849372148
StatePublished - Jan 1 2007

Fingerprint

Choroidal Neovascularization
Choroid Diseases
Angioid Streaks
Bruch Membrane
Histoplasmosis
Retinal Pigment Epithelium
Macular Degeneration
Retina
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kane, F. E., & Campochiaro, P. A. (2007). Choroidal neovascularization. In Age-Related Macular Degeneration, Second Edition (pp. 87-96). CRC Press.

Choroidal neovascularization. / Kane, Frances E.; Campochiaro, Peter A.

Age-Related Macular Degeneration, Second Edition. CRC Press, 2007. p. 87-96.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kane, FE & Campochiaro, PA 2007, Choroidal neovascularization. in Age-Related Macular Degeneration, Second Edition. CRC Press, pp. 87-96.
Kane FE, Campochiaro PA. Choroidal neovascularization. In Age-Related Macular Degeneration, Second Edition. CRC Press. 2007. p. 87-96
Kane, Frances E. ; Campochiaro, Peter A. / Choroidal neovascularization. Age-Related Macular Degeneration, Second Edition. CRC Press, 2007. pp. 87-96
@inbook{9394223b959c486c81bac27d6836ad19,
title = "Choroidal neovascularization",
abstract = "Despite substantial recent progress in treatment development, choroidal neovascularization (CNV) remains one of the most challenging problems faced by retina specialists. It is a common cause of severe visual loss in patients with age-related macular degeneration (AMD) and younger patients with one of many diseases that affect the choroid-Bruch’s membrane-retinal pigment epithelium (RPE) complex, including but not limited to ocular histoplasmosis, myopic degeneration, angioid streaks, and multifocal choroiditis. As our understanding of the molecular pathogenesis of CNV is increasing, new treatments are being developed which specifically target molecules that are involved. Therefore, it is critical to continue to elucidate the molecular mechanisms involved in CNV.",
author = "Kane, {Frances E.} and Campochiaro, {Peter A}",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780849372148",
pages = "87--96",
booktitle = "Age-Related Macular Degeneration, Second Edition",
publisher = "CRC Press",
address = "United States",

}

TY - CHAP

T1 - Choroidal neovascularization

AU - Kane, Frances E.

AU - Campochiaro, Peter A

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Despite substantial recent progress in treatment development, choroidal neovascularization (CNV) remains one of the most challenging problems faced by retina specialists. It is a common cause of severe visual loss in patients with age-related macular degeneration (AMD) and younger patients with one of many diseases that affect the choroid-Bruch’s membrane-retinal pigment epithelium (RPE) complex, including but not limited to ocular histoplasmosis, myopic degeneration, angioid streaks, and multifocal choroiditis. As our understanding of the molecular pathogenesis of CNV is increasing, new treatments are being developed which specifically target molecules that are involved. Therefore, it is critical to continue to elucidate the molecular mechanisms involved in CNV.

AB - Despite substantial recent progress in treatment development, choroidal neovascularization (CNV) remains one of the most challenging problems faced by retina specialists. It is a common cause of severe visual loss in patients with age-related macular degeneration (AMD) and younger patients with one of many diseases that affect the choroid-Bruch’s membrane-retinal pigment epithelium (RPE) complex, including but not limited to ocular histoplasmosis, myopic degeneration, angioid streaks, and multifocal choroiditis. As our understanding of the molecular pathogenesis of CNV is increasing, new treatments are being developed which specifically target molecules that are involved. Therefore, it is critical to continue to elucidate the molecular mechanisms involved in CNV.

UR - http://www.scopus.com/inward/record.url?scp=85056691027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056691027&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85056691027

SN - 9780849372148

SP - 87

EP - 96

BT - Age-Related Macular Degeneration, Second Edition

PB - CRC Press

ER -